BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cattaneo M, Bertinato EM, Birocchi S, Brizio C, Malavolta D, Manzoni M, Muscarella G, Orlandi M. Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified? Thromb Haemost 2020;120:1230-2. [PMID: 32349132 DOI: 10.1055/s-0040-1712097] [Cited by in Crossref: 127] [Cited by in F6Publishing: 176] [Article Influence: 63.5] [Reference Citation Analysis]
Number Citing Articles
1 Wifi MN, Morad MA, El Sheemy R, Abdeen N, Afify S, Abdalgaber M, Abdellatef A, Zaghloul M, Alboraie M, El-Kassas M. Hemostatic system and COVID-19 crosstalk: A review of the available evidence. World J Methodol 2022; 12(5): 331-349 [DOI: 10.5662/wjm.v12.i5.331] [Reference Citation Analysis]
2 Takayama W, Endo A, Otomo Y. Therapeutic anticoagulation using heparin in early phase severe coronavirus disease 2019: A retrospective study. The American Journal of Emergency Medicine 2022;58:84-8. [DOI: 10.1016/j.ajem.2022.05.031] [Reference Citation Analysis]
3 Nab L, Groenwold RHH, Klok FA, Bhoelan S, Kruip MJHA, Cannegieter SC. Estimating incidence of venous thromboembolism in COVID-19: Methodological considerations. Res Pract Thromb Haemost 2022;6:e12776. [PMID: 35992195 DOI: 10.1002/rth2.12776] [Reference Citation Analysis]
4 Li H, Chen S, Wang S, Yang S, Cao W, Liu S, Song Y, Li X, Li Z, Li R, Liu X, Wang C, Chen Y, Xie F, He Y, Liu M. Elevated D-dimer and Adverse In-hospital Outcomes in COVID-19 Patients and Synergism with Hyperglycemia. Infect Drug Resist 2022;15:3683-91. [PMID: 35855759 DOI: 10.2147/IDR.S367012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zaini M, Abu Farha R, Abutayeh R, Alsaud W, Hammoudeh A, Al-shudifat A, Al-kharabsheh T. Assessment of Jordanian physicians’ knowledge about venous thromboembolism risk and management among COVID-19 patients. Journal of Pharmaceutical Health Services Research 2022. [DOI: 10.1093/jphsr/rmac021] [Reference Citation Analysis]
6 Sedaghat F, Vadvala HV, Shan A, McMahon MT, Gawande RS. Incidence of Contrast-Associated Acute Kidney Injury in Renal-Competent COVID-19 Patients Undergoing Computed Chest Angiography. J Comput Assist Tomogr 2022. [PMID: 35675687 DOI: 10.1097/RCT.0000000000001337] [Reference Citation Analysis]
7 Glise Sandblad K, Rosengren A, Sörbo J, Jern S, Hansson P. Pulmonary embolism and deep vein thrombosis—comorbidities and temporary provoking factors in a register‐based study of 1.48 million people. Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12714] [Reference Citation Analysis]
8 Alahyari S, Moradi M, Rajaeinejad M, Jalaeikhoo H. Post-COVID-19 hematologic complications: a systematic review. Expert Rev Hematol 2022. [PMID: 35584541 DOI: 10.1080/17474086.2022.2080051] [Reference Citation Analysis]
9 Duhailib ZA, Oczkowski S, Polok K, Fronczek J, Szczeklik W, Piticaru J, Mammen MJ, Alshamsi F, Eikelboom J, Belley-cote EP, Alhazzani W. Venous and Arterial Thrombosis in COVID-19: An updated Narrative Review. Journal of Infection and Public Health 2022. [DOI: 10.1016/j.jiph.2022.05.003] [Reference Citation Analysis]
10 Jamiruddin MR, Meghla BA, Islam DZ, Tisha TA, Khandker SS, Khondoker MU, Haq MA, Adnan N, Haque M. Microfluidics Technology in SARS-CoV-2 Diagnosis and Beyond: A Systematic Review. Life 2022;12:649. [DOI: 10.3390/life12050649] [Reference Citation Analysis]
11 Prével R, Dupont A, Labrouche-Colomer S, Garcia G, Dewitte A, Rauch A, Goutay J, Caplan M, Jozefowicz E, Lanoix JP, Poissy J, Rivière E, Orieux A, Malvy D, Gruson D, Garçon L, Susen S, James C. Plasma Markers of Neutrophil Extracellular Trap Are Linked to Survival but Not to Pulmonary Embolism in COVID-19-Related ARDS Patients. Front Immunol 2022;13:851497. [PMID: 35371025 DOI: 10.3389/fimmu.2022.851497] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
12 Marquini GV, Martins SB, Oliveira LM, Dias MM, Takano CC, Sartori MGF. Effects of the COVID-19 Pandemic on Gynecological Health: An Integrative Review. Rev Bras Ginecol Obstet 2022;44:194-200. [PMID: 35213918 DOI: 10.1055/s-0042-1742294] [Reference Citation Analysis]
13 Angelini DE, Kaatz S, Rosovsky R, Zon RL, Pillai S, Robertson WE, Elavalakanar P, Patell R, Khorana A. COVID‐19 and venous thromboembolism: A narrative review. Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12666] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Mohammed Y, Goodlett DR, Cheng MP, Vinh DC, Lee TC, Mcgeer A, Sweet D, Tran K, Lee T, Murthy S, Boyd JH, Singer J, Walley KR, Patrick DM, Quan C, Ismail S, Amar L, Pal A, Bassawon R, Fesdekjian L, Gou K, Lamontagne F, Marshall J, Haljan G, Fowler R, Winston BW, Russell JA; ARBs CORONA I. Longitudinal Plasma Proteomics Analysis Reveals Novel Candidate Biomarkers in Acute COVID-19. J Proteome Res 2022. [PMID: 35143212 DOI: 10.1021/acs.jproteome.1c00863] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
15 Afshar ZM, Barary M, Babazadeh A, Hosseinzadeh R, Alijanpour A, Miri SR, Sio TT, Sullman MJM, Carson-Chahhoud K, Langer F, Ebrahimpour S. SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review. Rev Med Virol 2022;:e2327. [PMID: 35112763 DOI: 10.1002/rmv.2327] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Laino ME, Ammirabile A, Motta F, De Santis M, Savevski V, Francone M, Chiti A, Mannelli L, Selmi C, Monti L. Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart Involvement. Clin Rev Allergy Immunol 2022. [PMID: 35089505 DOI: 10.1007/s12016-022-08925-1] [Reference Citation Analysis]
17 Ihnatko M, Truchla I, Ihnatková L, Prohászka Z, Lazúrová I. Case Report: A Case of COVID Vaccine-Induced Thrombotic Thrombocytopenia Manifested as Pulmonary Embolism and Hemorrhagia. A First Reported Case From Slovakia. Front Med (Lausanne) 2021;8:789972. [PMID: 35059416 DOI: 10.3389/fmed.2021.789972] [Reference Citation Analysis]
18 Perera A, Chowdary P, Johnson J, Lamb L, Drebes A, Mir N, Sood T. A 10-fold and greater increase in D-dimer at admission in COVID-19 patients is highly predictive of pulmonary embolism in a retrospective cohort study. Ther Adv Hematol 2021;12:20406207211048364. [PMID: 34987740 DOI: 10.1177/20406207211048364] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Agarwal G, Hajra A, Chakraborty S, Patel N, Biswas S, Adler MK, Lavie CJ. Predictors and mortality risk of venous thromboembolism in patients with COVID-19: systematic review and meta-analysis of observational studies. Ther Adv Cardiovasc Dis 2022;16:17539447221105013. [PMID: 35762736 DOI: 10.1177/17539447221105013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Imbalzano E, Orlando L, Sciacqua A, Nato G, Dentali F, Nassisi V, Russo V, Camporese G, Bagnato G, Cicero AFG, Dattilo G, Vatrano M, Versace AG, Squadrito G, Di Micco P. Machine Learning to Calculate Heparin Dose in COVID-19 Patients with Active Cancer. J Clin Med 2021;11:219. [PMID: 35011959 DOI: 10.3390/jcm11010219] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Morici N, Podda G, Birocchi S, Bonacchini L, Merli M, Trezzi M, Massaini G, Agostinis M, Carioti G, Saverio Serino F, Gazzaniga G, Barberis D, Antolini L, Grazia Valsecchi M, Cattaneo M. Enoxaparin for thromboprophylaxis in hospitalized COVID-19 patients: The X-COVID-19 Randomized Trial. Eur J Clin Invest 2021;:e13735. [PMID: 34958123 DOI: 10.1111/eci.13735] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
22 Yassin A, Abdelkader MA, Mohammed RM, Osman AM. CT pulmonary angiography in COVID-19 pneumonia: relationship between pulmonary embolism and disease severity. Egypt J Radiol Nucl Med 2021;52. [DOI: 10.1186/s43055-020-00389-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
23 Zarkesh K, Entezar-Almahdi E, Ghasemiyeh P, Akbarian M, Bahmani M, Roudaki S, Fazlinejad R, Mohammadi-Samani S, Firouzabadi N, Hosseini M, Farjadian F. Drug-based therapeutic strategies for COVID-19-infected patients and their challenges. Future Microbiol 2021;16:1415-51. [PMID: 34812049 DOI: 10.2217/fmb-2021-0116] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
24 Hsieh JYC, Kan JYL, Mattar SAM, Qin Y. The clinical implications of sinus tachycardia in mild COVID-19 infection: A retrospective cohort study. SAGE Open Med 2021;9:20503121211054973. [PMID: 34733514 DOI: 10.1177/20503121211054973] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Augustine R, S A, Nayeem A, Salam SA, Augustine P, Dan P, Maureira P, Mraiche F, Gentile C, Hansbro PM, McClements L, Hasan A. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation. Chem Biol Interact 2021;351:109738. [PMID: 34740598 DOI: 10.1016/j.cbi.2021.109738] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
26 Goßlau Y, Warm TD, Hernandez Cancino EF, Braun G, Spring O, Zerwes S, Hyhlik-Dürr A. [Deep Vein Thrombosis in Intensive Care Patients with COVID-19 Infection - Impact of a Standardised Therapeutic Regimen]. Zentralbl Chir 2021;146:605-11. [PMID: 34706375 DOI: 10.1055/a-1630-8163] [Reference Citation Analysis]
27 Di Tano G, Dede M, Pellicelli I, Martinelli E, Moschini L, Calvaruso E, Danzi GB. Pulmonary embolism in patients with COVID-19 pneumonia on adequate oral anticoagulation. J Thromb Thrombolysis 2021. [PMID: 34708314 DOI: 10.1007/s11239-021-02589-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Cacciola R, Gentilini Cacciola E, Vecchio V, Cacciola E. Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy. J Thromb Thrombolysis 2021. [PMID: 34687400 DOI: 10.1007/s11239-021-02583-4] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
29 Caillon A, Trimaille A, Favre J, Jesel L, Morel O, Kauffenstein G. Role of neutrophils, platelets, and extracellular vesicles and their interactions in COVID-19-associated thrombopathy. J Thromb Haemost 2021. [PMID: 34672094 DOI: 10.1111/jth.15566] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
30 Pekrul I, Spannagl M, Nitschmann S. [Anticoagulation in patients with COVID-19]. Internist (Berl) 2021;62:1253-5. [PMID: 34636950 DOI: 10.1007/s00108-021-01190-y] [Reference Citation Analysis]
31 Ho FK, Man KKC, Toshner M, Church C, Celis-Morales C, Wong ICK, Berry C, Sattar N, Pell JP. Thromboembolic Risk in Hospitalized and Nonhospitalized COVID-19 Patients: A Self-Controlled Case Series Analysis of a Nationwide Cohort. Mayo Clin Proc 2021;96:2587-97. [PMID: 34607634 DOI: 10.1016/j.mayocp.2021.07.002] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Oliynyk O, Barg W, Slifirczyk A, Oliynyk Y, Dubrov S, Gurianov V, Rorat M. Comparison of the Effect of Unfractionated Heparin and Enoxaparin Sodium at Different Doses on the Course of COVID-19-Associated Coagulopathy. Life (Basel) 2021;11:1032. [PMID: 34685403 DOI: 10.3390/life11101032] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
33 Razi M, Gu J, He X, Kong J, Ahmed MJ. Venous thromboembolism in patients with COVID-19. A prevalent and a preventable complication of the pandemic. J Interv Med 2021;4:62-5. [PMID: 34557323 DOI: 10.1016/j.jimed.2021.02.006] [Reference Citation Analysis]
34 Riu P, Albarello F, Di Stefano F, Vergori A, D'Abramo A, Cerini C, Nocioni M, Morucci M, Tetaj N, Cristofaro M, Schininà V, Campioni P, Petrone A, Fusco N, Marchioni L, Antinori A, Nicastri E, Cianni R, Ianniello S. Management of Spontaneous Bleeding in COVID-19 Inpatients: Is Embolization Always Needed? J Clin Med 2021;10:4119. [PMID: 34575230 DOI: 10.3390/jcm10184119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Polo Friz H, Gelfi E, Orenti A, Motto E, Primitz L, Donzelli T, Intotero M, Scarpazza P, Vighi G, Cimminiello C, Boracchi P. Acute pulmonary embolism in patients presenting pulmonary deterioration after hospitalisation for non-critical COVID-19. Intern Med J 2021;51:1236-42. [PMID: 33834578 DOI: 10.1111/imj.15307] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
36 García-Ceberino PM, Faro-Míguez N, Beltrán-Ávila FJ, Fernández-Reyes D, Gallardo-Muñoz I, Guirao-Arrabal E. Point of care ultrasound (POCUS) in diagnosis of proximal deep vein thrombosis among COVID-19 hospitalized patients with a high rate of low molecular weight heparin prophylaxis. Med Clin (Engl Ed) 2021;157:172-5. [PMID: 34458580 DOI: 10.1016/j.medcle.2021.01.013] [Reference Citation Analysis]
37 AbdelHamid SG, Refaat AA, Benjamin AM, Elmawardy LA, Elgendy LA, Manolly MM, Elmaksoud NA, Sherif N, Hamdy NM. Deciphering epigenetic(s) role in modulating susceptibility to and severity of COVID-19 infection and/or outcome: a systematic rapid review. Environ Sci Pollut Res Int 2021. [PMID: 34383213 DOI: 10.1007/s11356-021-15588-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Okeahialam BN. Serine protease inhibitors could be of benefit in the treatment of COVID-19 disease. Ther Adv Infect Dis 2021;8:20499361211032048. [PMID: 34345429 DOI: 10.1177/20499361211032048] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Alkhamis A, Alshamali Y, Alyaqout K, Lari E, Alkhamis MA, Althuwaini S, Lari A, Alfili M, Alkhayat A, Jamal MH, Alsabah S. Prevalence, predictors and outcomes of bleeding events in patients with COVID-19 infection on anticoagulation: Retrospective cohort study. Ann Med Surg (Lond) 2021;68:102567. [PMID: 34306676 DOI: 10.1016/j.amsu.2021.102567] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Tiotiu A, Chong Neto H, Bikov A, Kowal K, Steiropoulos P, Labor M, Cherrez-Ojeda I, Badellino H, Emelyanov A, Garcia R, Guidos G. Impact of the COVID-19 pandemic on the management of chronic noninfectious respiratory diseases. Expert Rev Respir Med 2021;15:1035-48. [PMID: 34253132 DOI: 10.1080/17476348.2021.1951707] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
41 Viurcos-Sanabria R, Escobedo G. Immunometabolic bases of type 2 diabetes in the severity of COVID-19. World J Diabetes 2021; 12(7): 1026-1041 [PMID: 34326952 DOI: 10.4239/wjd.v12.i7.1026] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
42 Zhang JC, Li T. Delayed retroperitoneal hemorrhage during extracorporeal membrane oxygenation in COVID-19 patients: A case report and literature review. World J Clin Cases 2021; 9(19): 5203-5210 [PMID: 34307568 DOI: 10.12998/wjcc.v9.i19.5203] [Cited by in CrossRef: 3] [Article Influence: 3.0] [Reference Citation Analysis]
43 Semeraro N, Colucci M. The Prothrombotic State Associated with SARS-CoV-2 Infection: Pathophysiological Aspects. Mediterr J Hematol Infect Dis 2021;13:e2021045. [PMID: 34276914 DOI: 10.4084/MJHID.2021.045] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
44 Gabara C, Solarat B, Castro P, Fernández S, Badia J, Toapanta D, Schulman S, Reverter J, Soriano A, Moisés J, Aibar J. Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients. Medicina Intensiva 2021. [DOI: 10.1016/j.medin.2021.07.004] [Reference Citation Analysis]
45 Smadja DM, Mentzer SJ, Fontenay M, Laffan MA, Ackermann M, Helms J, Jonigk D, Chocron R, Pier GB, Gendron N, Pons S, Diehl JL, Margadant C, Guerin C, Huijbers EJM, Philippe A, Chapuis N, Nowak-Sliwinska P, Karagiannidis C, Sanchez O, Kümpers P, Skurnik D, Randi AM, Griffioen AW. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects. Angiogenesis 2021. [PMID: 34184164 DOI: 10.1007/s10456-021-09805-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 35] [Article Influence: 1.0] [Reference Citation Analysis]
46 Zanframundo G, Graziani A, Barbara C, Francesco P, Teresa MM, Cristian C, Pierluigi G, Ludovico D. Resolution of pulmonary artery thrombosis in patients with moderate COVID-19 disease. J Community Hosp Intern Med Perspect 2021;11:470-2. [PMID: 34211650 DOI: 10.1080/20009666.2021.1921908] [Reference Citation Analysis]
47 Pergola V, Ocagli H, Lorenzoni G, Azzolina D, Leoni L, Mancuso D, Palermo C, Previtero M, Iliceto S, Gregori D, Di Salvo G. Prevalence of Thromboembolic Complications in COVID-19 Infection: A Systematic Review and Meta-Analysis. EMJ. [DOI: 10.33590/emj/20-00237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 An X, Duan L, Zhang YH, Jin, Zhao S, Zhou RR, Duan Y, Lian F, Tong X. The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19. Chin Med 2021;16:44. [PMID: 34099015 DOI: 10.1186/s13020-021-00454-x] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
49 Mulder MMG, Brandts L, Brüggemann RAG, Koelmann M, Streng AS, Olie RH, Gietema HA, Spronk HMH, van der Horst ICC, Sels JEM, Wildberger JE, van Kuijk SMJ, Schnabel RM, Ten Cate H, Henskens YMC, van Bussel BCT. Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 infection; the prospective Maastricht intensive care COVID cohort. Thromb J 2021;19:35. [PMID: 34059058 DOI: 10.1186/s12959-021-00286-7] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
50 Cattaneo M. Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines. Eur J Intern Med 2021;89:22-4. [PMID: 34092488 DOI: 10.1016/j.ejim.2021.05.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
51 Caramaschi S, Kapp ME, Miller SE, Eisenberg R, Johnson J, Epperly G, Maiorana A, Silvestri G, Giannico GA. Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review. Mod Pathol 2021;34:1614-33. [PMID: 34031537 DOI: 10.1038/s41379-021-00814-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
52 Fares Y, Sinzogan-Eyoum YC, Billoir P, Bogaert A, Armengol G, Alexandre K, Lammens J, Grall M, Levesque H, Benhamou Y, Miranda S. Systematic screening for a proximal DVT in COVID-19 hospitalized patients: Results of a comparative study. J Med Vasc 2021;46:163-70. [PMID: 34238510 DOI: 10.1016/j.jdmv.2021.05.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Trimaille A, Curtiaud A, Matsushita K, Marchandot B, Von Hunolstein JJ, Sato C, Leonard-Lorant I, Sattler L, Grunebaum L, Ohana M, Ohlmann P, Jesel L, Morel O. Acute Pulmonary Embolism in Patients with and without COVID-19. J Clin Med 2021;10:2045. [PMID: 34064556 DOI: 10.3390/jcm10102045] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Trunz LM, Lee P, Lange SM, Pomeranz CL, Needleman L, Ford RW, Karambelkar A, Sundaram B. Imaging approach to COVID-19 associated pulmonary embolism. Int J Clin Pract 2021;:e14340. [PMID: 33966326 DOI: 10.1111/ijcp.14340] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Jiménez S, Miró Ò, Llorens P, Martín-Sánchez FJ, Burillo-Putze G, Piñera P, Martín A, Alquézar A, García-Lamberechts EJ, Jacob J, Grima MLL, Millán J, Molina F, Albero PB, Cardozo C, Mòdol JM, Aguirre A, Gaya R, Adroher M, Llauger L, Díaz JJL, González NC, Aragües PL, Gómez AP, Del Castillo JG; Spanish Investigators on Emergency Situations TeAm (SIESTA) network. Incidence, risk factors, clinical characteristics and outcomes of deep venous thrombosis in patients with COVID-19 attending the Emergency Department: results of the UMC-19-S8. Eur J Emerg Med 2021;28:218-26. [PMID: 33904528 DOI: 10.1097/MEJ.0000000000000783] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
56 Kohansal Vajari M, Shirin M, Pourbagheri-Sigaroodi A, Akbari ME, Abolghasemi H, Bashash D. COVID-19-related coagulopathy: A review of pathophysiology and pharmaceutical management. Cell Biol Int 2021. [PMID: 33945651 DOI: 10.1002/cbin.11623] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
57 Yu B, Gutierrez VP, Carlos A, Hoge G, Pillai A, Kelly JD, Menon V. Empiric use of anticoagulation in hospitalized patients with COVID-19: a propensity score-matched study of risks and benefits. Biomark Res 2021;9:29. [PMID: 33933168 DOI: 10.1186/s40364-021-00283-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
58 Nikolic M, Simovic S, Novkovic L, Jokovic V, Djokovic D, Muric N, Bazic Sretenovic D, Jovanovic J, Pantic K, Cekerevac I. Obesity and sleep apnea as a significant comorbidities in COVID-19 - A case report. Obes Res Clin Pract 2021;15:281-4. [PMID: 33933379 DOI: 10.1016/j.orcp.2021.04.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Romanov A, Bach M, Yang S, Franzeck FC, Sommer G, Anastasopoulos C, Bremerich J, Stieltjes B, Weikert T, Sauter AW. Automated CT Lung Density Analysis of Viral Pneumonia and Healthy Lungs Using Deep Learning-Based Segmentation, Histograms and HU Thresholds. Diagnostics (Basel) 2021;11:738. [PMID: 33919094 DOI: 10.3390/diagnostics11050738] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
60 Abdelmohsen MA, Alkandari BM, Abdel Razek AAK, Tobar AM, Gupta VK, Elsebaie N. Abdominal Computed Tomography Angiography and Venography in Evaluation of Hemorrhagic and Thrombotic lesions in Hospitalized COVID-19 patients. Clin Imaging 2021;79:12-9. [PMID: 33865171 DOI: 10.1016/j.clinimag.2021.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
61 Bobadilla-Rosado LO, Mier Y Teran-Ellis S, Lopez-Pena G, Anaya-Ayala JE, Hinojosa CA. Clinical Outcomes of Pulmonary Embolism in Mexican Patients With COVID-19. Clin Appl Thromb Hemost 2021;27:10760296211008988. [PMID: 33813911 DOI: 10.1177/10760296211008988] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Kollias A, Kyriakoulis KG, Lagou S, Kontopantelis E, Stergiou GS, Syrigos K. Venous thromboembolism in COVID-19: A systematic review and meta-analysis. Vasc Med 2021;26:415-25. [PMID: 33818197 DOI: 10.1177/1358863X21995566] [Cited by in Crossref: 6] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
63 Melegari G, Rivi V, Zelent G, Nasillo V, De Santis E, Melegari A, Bevilacqua C, Zoli M, Meletti S, Barbieri A. Mild to Severe Neurological Manifestations of COVID-19: Cases Reports. Int J Environ Res Public Health 2021;18:3673. [PMID: 33915937 DOI: 10.3390/ijerph18073673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
64 Thachil J, Khorana A, Carrier M. Similarities and perspectives on the two C's-Cancer and COVID-19. J Thromb Haemost 2021;19:1161-7. [PMID: 33725410 DOI: 10.1111/jth.15294] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
65 Vos CG, Gravendeel J, Keller BPJA. Three cases of spontaneous major bleeding in patients with a COVID-19 infection. Acta Chir Belg 2021;:1-4. [PMID: 33769205 DOI: 10.1080/00015458.2021.1902092] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Scardapane A, Villani L, Bavaro DF, Passerini F, Ianora AAS, Lucarelli NM, Angarano G, Portincasa P, Palmieri VO, Saracino A. Pulmonary Artery Filling Defects in COVID-19 Patients Revealed Using CT Pulmonary Angiography: A Predictable Complication? Biomed Res Int 2021;2021:8851736. [PMID: 33778084 DOI: 10.1155/2021/8851736] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
67 Longchamp G, Manzocchi-Besson S, Longchamp A, Righini M, Robert-Ebadi H, Blondon M. Proximal deep vein thrombosis and pulmonary embolism in COVID-19 patients: a systematic review and meta-analysis. Thromb J 2021;19:15. [PMID: 33750409 DOI: 10.1186/s12959-021-00266-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
68 Kruip MJHA, Cannegieter SC, Ten Cate H, van Gorp ECM, Juffermans NP, Klok FA, Maas C, Vonk-Noordegraaf A; Dutch COVID Thrombosis Coalition study group. Caging the dragon: Research approach to COVID-19-related thrombosis. Res Pract Thromb Haemost 2021;5:278-90. [PMID: 33733026 DOI: 10.1002/rth2.12470] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
69 Ibrahim RS, Mahrous RSR, Abu El-Khair RM, Ross SA, Omar AA, Fathy HM. Biologically guided isolation and ADMET profile of new factor Xa inhibitors from Glycyrrhiza glabra roots using in vitro and in silico approaches. RSC Adv 2021;11:9995-10001. [PMID: 35423517 DOI: 10.1039/d1ra00359c] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
70 Kaptein FHJ, Stals MAM, Huisman MV, Klok FA. Prophylaxis and treatment of COVID-19 related venous thromboembolism. Postgrad Med 2021;133:27-35. [PMID: 33657964 DOI: 10.1080/00325481.2021.1891788] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
71 García-Ceberino PM, Faro-Míguez N, Beltrán-Ávila FJ, Fernández-Reyes D, Gallardo-Muñoz I, Guirao-Arrabal E. Point of care ultrasound (POCUS) in diagnosis of proximal deep vein thrombosis among COVID-19 hospitalized patients with a high rate of low molecular weight heparin prophylaxis. Med Clin (Barc) 2021;157:172-5. [PMID: 33773764 DOI: 10.1016/j.medcli.2021.01.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Tan BK, Mainbourg S, Friggeri A, Bertoletti L, Douplat M, Dargaud Y, Grange C, Lobbes H, Provencher S, Lega JC. Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis. Thorax 2021:thoraxjnl-2020-215383. [PMID: 33622981 DOI: 10.1136/thoraxjnl-2020-215383] [Cited by in Crossref: 21] [Cited by in F6Publishing: 83] [Article Influence: 21.0] [Reference Citation Analysis]
73 Turecek PL, Peck RC, Rangarajan S, Reilly-Stitt C, Laffan MA, Kazmi R, James I, Dushianthan A, Schrenk G, Gritsch H, Ewenstein BM, Mellgard B, Erdlenbruch W, Jain N, Binder NB, Mumford AD. Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19. Thromb Res 2021;201:100-12. [PMID: 33662796 DOI: 10.1016/j.thromres.2021.02.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
74 Cardillo G, Viggiano GV, Russo V, Mangiacapra S, Cavalli A, Castaldo G, Agrusta F, Bellizzi A, Amitrano M, Iannuzzo M, Sacco C, Lodigiani C, Fontanella A, Di Micco P; FondenoxavidStudy Group. Antithrombotic and Anti-Inflammatory Effects of Fondaparinux and Enoxaparin in Hospitalized COVID-19 Patients: The FONDENOXAVID Study. J Blood Med 2021;12:69-75. [PMID: 33603528 DOI: 10.2147/JBM.S285214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
75 Ozsu S, Gunay E, Konstantinides SV. A review of venous thromboembolism in COVID-19: A clinical perspective. Clin Respir J 2021;15:506-12. [PMID: 33484090 DOI: 10.1111/crj.13330] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
76 Goshua G, Lee AI. Harmonizing hypercoagulable heterogeneity: Baseline VTE risk in COVID-19. Res Pract Thromb Haemost 2021;5:9-10. [PMID: 33537523 DOI: 10.1002/rth2.12448] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
77 Vergori A, Pianura E, Lorenzini P, D'Abramo A, Di Stefano F, Grisetti S, Vita S, Pinnetti C, Donno DR, Marini MC, Nicastri E, Ianniello S, Antinori A; ReCOVeRI Study Group. Spontaneous ilio-psoas haematomas (IPHs): a warning for COVID-19 inpatients. Ann Med 2021;53:295-301. [PMID: 33491498 DOI: 10.1080/07853890.2021.1875498] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
78 Tazi Mezalek Z. [COVID-19: Coagulopathy and thrombosis]. Rev Med Interne 2021;42:93-100. [PMID: 33509669 DOI: 10.1016/j.revmed.2020.12.014] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Weber C, Rigby A, Lip GYH. Thrombosis and Haemostasis 2020 Editors' Choice Papers. Thromb Haemost 2021;121:109-14. [PMID: 33477198 DOI: 10.1055/s-0040-1722171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
80 Page EM, Ariëns RAS. Mechanisms of thrombosis and cardiovascular complications in COVID-19. Thromb Res 2021;200:1-8. [PMID: 33493983 DOI: 10.1016/j.thromres.2021.01.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
81 Lapébie FX, Minville V, Ribes A, Combis B, Thery A, Geeraerts T, Silva S, Bura-Rivière A, Vardon-Bounes F. Systematic Screening for Deep Vein Thrombosis in Critically Ill Inpatients With COVID-19: Impact on the Incidence of Venous Thromboembolism. Front Med (Lausanne) 2020;7:624808. [PMID: 33521028 DOI: 10.3389/fmed.2020.624808] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
82 Schiaffino S, Giacomazzi F, Esseridou A, Cozzi A, Carriero S, Mazzaccaro DP, Nano G, Di Leo G, Spagnolo P, Sardanelli F. Pulmonary thromboembolism in coronavirus disease 2019 patients undergoing thromboprophylaxis. Medicine (Baltimore) 2021;100:e24002. [PMID: 33429763 DOI: 10.1097/MD.0000000000024002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
83 Priori A, Baisi A, Banderali G, Biglioli F, Bulfamante G, Canevini MP, Cariati M, Carugo S, Cattaneo M, Cerri A, Chiumello D, Colosio C, Cozzolino M, D'Arminio Monforte A, Felisati G, Ferrari D, Gambini O, Gardinali M, Marconi AM, Olivari I, Orfeo NV, Opocher E, Pietrogrande L, Previtera A, Rossetti L, Vegni E, Toschi V, Zuin M, Centanni S. The Many Faces of Covid-19 at a Glance: A University Hospital Multidisciplinary Account From Milan, Italy. Front Public Health 2020;8:575029. [PMID: 33490013 DOI: 10.3389/fpubh.2020.575029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
84 Di Castelnuovo A, Costanzo S, Antinori A, Berselli N, Blandi L, Bonaccio M, Cauda R, Guaraldi G, Menicanti L, Mennuni M, Parruti G, Patti G, Santilli F, Signorelli C, Vergori A, Abete P, Ageno W, Agodi A, Agostoni P, Aiello L, Al Moghazi S, Arboretti R, Astuto M, Aucella F, Barbieri G, Bartoloni A, Bonfanti P, Cacciatore F, Caiano L, Carrozzi L, Cascio A, Ciccullo A, Cingolani A, Cipollone F, Colomba C, Colombo C, Crosta F, Danzi GB, D'Ardes D, de Gaetano Donati K, Di Gennaro F, Di Tano G, D'Offizi G, Fantoni M, Fusco FM, Gentile I, Gianfagna F, Grandone E, Graziani E, Grisafi L, Guarnieri G, Larizza G, Leone A, Maccagni G, Madaro F, Maitan S, Mancarella S, Mapelli M, Maragna R, Marcucci R, Maresca G, Marongiu S, Marotta C, Marra L, Mastroianni F, Mazzitelli M, Mengozzi A, Menichetti F, Meschiari M, Milic J, Minutolo F, Molena B, Montineri A, Mussini C, Musso M, Niola D, Odone A, Olivieri M, Palimodde A, Parisi R, Pasi E, Pesavento R, Petri F, Pinchera B, Poletti V, Ravaglia C, Rognoni A, Rossato M, Rossi M, Sangiovanni V, Sanrocco C, Scorzolini L, Sgariglia R, Simeone PG, Taddei E, Torti C, Vettor R, Vianello A, Vinceti M, Virano A, Vocciante L, De Caterina R, Iacoviello L. Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study. Thromb Haemost 2021;121:1054-65. [PMID: 33412596 DOI: 10.1055/a-1347-6070] [Cited by in Crossref: 19] [Cited by in F6Publishing: 36] [Article Influence: 19.0] [Reference Citation Analysis]
85 Lalatović J, Golubović J, Miljević M, Lukić F, Jeličić S, Kraišnik N, Aleksić A, Kalaba Z, Vidović B, Tošković B, Crnokrak B, Mrda J, Zdravković M, Mrda D. Transcatheter Arterial Embolization as a Treatment for Life-Threatening Retroperitoneal Hemorrhage in COVID-19 Patients on Anticoagulant Therapy. OJEM 2021;09:209-15. [DOI: 10.4236/ojem.2021.94021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Henrina J, Santosa Putra IC, Cahyadi I, Lawrensia S, Hadi Gunawan HF, Cahyadi A, Franke J, Suciadi LP. Clinical characteristics and outcomes of venous thromboembolism in patients hospitalized for COVID-19: Systematic review and meta-analysis. Thrombosis Update 2021;2:100037. [DOI: 10.1016/j.tru.2021.100037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
87 Patell R, Chiasakul T, Bauer E, Zwicker JI. Pharmacologic Thromboprophylaxis and Thrombosis in Hospitalized Patients with COVID-19: A Pooled Analysis. Thromb Haemost 2021;121:76-85. [PMID: 33378787 DOI: 10.1055/s-0040-1721664] [Cited by in Crossref: 14] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
88 Cerdà P, Ribas J, Iriarte A, Mora-Luján JM, Torres R, Del Río B, Jofre HI, Ruiz Y, Huguet M, Fuset MP, Martínez-Yélamos S, Santos S, Llecha N, Corbella X, Riera-Mestre A. Blood test dynamics in hospitalized COVID-19 patients: Potential utility of D-dimer for pulmonary embolism diagnosis. PLoS One 2020;15:e0243533. [PMID: 33370304 DOI: 10.1371/journal.pone.0243533] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
89 Waite AAC, Hamilton DO, Pizzi R, Ageno W, Welters ID. Hypercoagulopathy in Severe COVID-19: Implications for Acute Care. Thromb Haemost 2020;120:1654-67. [PMID: 33368088 DOI: 10.1055/s-0040-1721487] [Cited by in Crossref: 4] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
90 Sadoughi F, Maleki Dana P, Hallajzadeh J, Asemi Z, Mansournia MA, Yousefi B. Coagulopathy: Another side effect of coronavirus infection. J Cardiovasc Thorac Res 2021;13:15-22. [PMID: 33815697 DOI: 10.34172/jcvtr.2020.59] [Reference Citation Analysis]
91 Chen B, Jiang C, Han B, Guan C, Fang G, Yan S, Wang K, Liu L, Conlon CP, Xie R, Song R. High prevalence of occult thrombosis in cases of mild/moderate COVID-19. Int J Infect Dis 2021;104:77-82. [PMID: 33352324 DOI: 10.1016/j.ijid.2020.12.042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
92 Kory P, Meduri GU, Iglesias J, Varon J, Marik PE. Clinical and Scientific Rationale for the "MATH+" Hospital Treatment Protocol for COVID-19. J Intensive Care Med 2021;36:135-56. [PMID: 33317385 DOI: 10.1177/0885066620973585] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
93 Suh YJ, Hong H, Ohana M, Bompard F, Revel MP, Valle C, Gervaise A, Poissy J, Susen S, Hékimian G, Artifoni M, Periard D, Contou D, Delaloye J, Sanchez B, Fang C, Garzillo G, Robbie H, Yoon SH. Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis. Radiology 2021;298:E70-80. [PMID: 33320063 DOI: 10.1148/radiol.2020203557] [Cited by in Crossref: 30] [Cited by in F6Publishing: 121] [Article Influence: 15.0] [Reference Citation Analysis]
94 Hill JB, Garcia D, Crowther M, Savage B, Peress S, Chang K, Deitelzweig S. Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study. Blood Adv 2020;4:5373-7. [PMID: 33137202 DOI: 10.1182/bloodadvances.2020003083] [Cited by in Crossref: 17] [Cited by in F6Publishing: 30] [Article Influence: 8.5] [Reference Citation Analysis]
95 Zhang R, Ni L, Di X, Wang X, Ma B, Niu S, Liu C. Systematic review and meta-analysis of the prevalence of venous thromboembolic events in novel coronavirus disease-2019 patients. J Vasc Surg Venous Lymphat Disord 2021;9:289-298.e5. [PMID: 33309903 DOI: 10.1016/j.jvsv.2020.11.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
96 Al-Mohammad A, Partridge DG, Fent G, Watson O, Lewis NT, Storey RF, Makris M, Chico TJ. The cardiac complications of COVID-19: many publications, multiple uncertainties. Vasc Biol 2020;2:R105-14. [PMID: 33283157 DOI: 10.1530/VB-20-0009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Ricciardolo FLM, Bertolini F, Carriero V, Högman M. Nitric oxide's physiologic effects and potential as a therapeutic agent against COVID-19. J Breath Res 2020;15:014001. [PMID: 33080582 DOI: 10.1088/1752-7163/abc302] [Cited by in Crossref: 2] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
98 Pascual Pareja JF, García-Caballero R, Soler Rangel L, Vázquez-Ronda MA, Roa Franco S, Navarro Jiménez G, Moreno Palanco MA, González-Ruano P, López-Menchaca R, Ruíz-Seco P, Pagán Muñoz B, Gómez Gómez A, Pérez-Monte B, Fuerte Martínez R, Valle López JL, Muñoz Blanco A, Rábago Lorite I, Martínez Martín P, Serralta San Martín G, Gómez-Cerezo JF; en nombre del grupo de trabajo HUIS-COVID-19. [Effectiveness of glucocorticoids in patients hospitalized for severe SARS-CoV-2 pneumonia]. Med Clin (Barc) 2021;156:221-8. [PMID: 33380371 DOI: 10.1016/j.medcli.2020.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Khan MZ, Jamal Y, Sutton B, Rauf F. Venous thromboembolism in patients with COVID-19 and correlation with D-dimers: a single-centre experience. BMJ Open Respir Res 2020;7:e000779. [PMID: 33199402 DOI: 10.1136/bmjresp-2020-000779] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
100 Henry BM, Benoit SW, de Oliveira MHS, Lippi G, Favaloro EJ, Benoit JL. ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID-19: Evidence of SARS-CoV-2 induced secondary thrombotic microangiopathy. Int J Lab Hematol 2021;43 Suppl 1:129-36. [PMID: 33270980 DOI: 10.1111/ijlh.13415] [Cited by in Crossref: 8] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
101 Al-Horani RA. Potential Therapeutic Roles for Direct Factor Xa Inhibitors in Coronavirus Infections. Am J Cardiovasc Drugs 2020;20:525-33. [PMID: 32918208 DOI: 10.1007/s40256-020-00438-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
102 Perea Polak A, Romero Madrid B, García Ocaña PP, Lomeña Alvarez G, Martínez Pilar L, Gómez-Moyano E. Complement-mediated thrombogenic vasculopathy in COVID-19. Int J Dermatol 2021;60:229-32. [PMID: 33259066 DOI: 10.1111/ijd.15267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
103 Boonyawat K, Chantrathammachart P, Numthavaj P, Nanthatanti N, Phusanti S, Phuphuakrat A, Niparuck P, Angchaisuksiri P. Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis. Thromb J 2020;18:34. [PMID: 33292258 DOI: 10.1186/s12959-020-00248-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 34] [Article Influence: 10.5] [Reference Citation Analysis]
104 Jiménez D, García-Sanchez A, Rali P, Muriel A, Bikdeli B, Ruiz-Artacho P, Le Mao R, Rodríguez C, Hunt BJ, Monreal M. Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis. Chest 2021;159:1182-96. [PMID: 33217420 DOI: 10.1016/j.chest.2020.11.005] [Cited by in Crossref: 66] [Cited by in F6Publishing: 148] [Article Influence: 33.0] [Reference Citation Analysis]
105 Sridharan GK, Vegunta R, Rokkam VRP, Meyyur Aravamudan V, Vegunta R, Khan SR, Ponnada S, Boregowda U, Prudhvi K, Chamarthi G, Mohan BP. Venous Thromboembolism in Hospitalized COVID-19 Patients. Am J Ther 2020;27:e599-610. [PMID: 33156016 DOI: 10.1097/MJT.0000000000001295] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
106 Pancani R, Villari L, Foci V, Parri G, Barsotti F, Patrucco F, Malerba M, Vincenti R, Carrozzi L, Celi A. Lower limb deep vein thrombosis in COVID-19 patients admitted to intermediate care respiratory units. Thromb Res 2021;197:44-7. [PMID: 33181470 DOI: 10.1016/j.thromres.2020.10.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
107 Dobesh PP, Trujillo TC. Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19. Pharmacotherapy 2020;40:1130-51. [PMID: 33006163 DOI: 10.1002/phar.2465] [Cited by in Crossref: 22] [Cited by in F6Publishing: 35] [Article Influence: 11.0] [Reference Citation Analysis]
108 Kreidieh F, Temraz S. SARS-CoV-2 Infected Patient: from a Hematologist's Perspective. Mediterr J Hematol Infect Dis 2020;12:e2020078. [PMID: 33194152 DOI: 10.4084/MJHID.2020.078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
109 Birocchi S, Manzoni M, Podda GM, Casazza G, Cattaneo M. High rates of pulmonary artery occlusions in COVID-19. A meta-analysis. Eur J Clin Invest 2021;51:e13433. [PMID: 33053206 DOI: 10.1111/eci.13433] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
110 Yethindra V, Tagaev T. Decreased mortality among hospitalized coronavirus disease 2019 patients who underwent anticoagulant therapy with heparin. Indian J Pharmacol 2020;52:337-8. [PMID: 33078738 DOI: 10.4103/ijp.IJP_584_20] [Reference Citation Analysis]
111 Pisano TJ, Joki J, Hon B, Cuccurullo S. Pulmonary Embolism After Acute Spinal Cord Injury and COVID-19. Am J Phys Med Rehabil 2020;99:982-5. [PMID: 32858533 DOI: 10.1097/PHM.0000000000001578] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
112 Schulman S, Hu Y, Konstantinides S. Venous Thromboembolism in COVID-19. Thromb Haemost 2020;120:1642-53. [PMID: 33099284 DOI: 10.1055/s-0040-1718532] [Cited by in Crossref: 11] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
113 Fernández-capitán C, Barba R, Díaz-pedroche MDC, Sigüenza P, Demelo-rodriguez P, Siniscalchi C, Pedrajas JM, Farfán-sedano AI, Olivera PE, Gómez-cuervo C, Llamas P, Villares P, Sanchez O, López-reyes R, Catella J, Bikdeli B, Weinberg I, Tafur AJ, Jiménez D, Monreal M. Presenting Characteristics, Treatment Patterns, and Outcomes among Patients with Venous Thromboembolism during Hospitalization for COVID-19. Semin Thromb Hemost 2021;47:351-61. [DOI: 10.1055/s-0040-1718402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
114 Gąsecka A, Borovac JA, Guerreiro RA, Giustozzi M, Parker W, Caldeira D, Chiva-Blanch G. Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment. Cardiovasc Drugs Ther 2021;35:215-29. [PMID: 33074525 DOI: 10.1007/s10557-020-07084-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 46] [Article Influence: 16.5] [Reference Citation Analysis]
115 Pamukçu B. Inflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2. Anatol J Cardiol 2020;24:224-34. [PMID: 33001051 DOI: 10.14744/AnatolJCardiol.2020.56727] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
116 Ceriello A. Diabetes, D-dimer and COVID-19: The possible role of glucose control. Diabetes Metab Syndr 2020;14:1987. [PMID: 33080539 DOI: 10.1016/j.dsx.2020.10.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
117 Brüggemann RAG, Spaetgens B, Gietema HA, Brouns SHA, Stassen PM, Magdelijns FJ, Rennenberg RJ, Henry RMA, Mulder MMG, van Bussel BCT, Schnabel RM, van der Horst ICC, Wildberger JE, Stehouwer CDA, Ten Cate H. The prevalence of pulmonary embolism in patients with COVID-19 and respiratory decline: A three-setting comparison. Thromb Res 2020;196:486-90. [PMID: 33091701 DOI: 10.1016/j.thromres.2020.10.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
118 Taus F, Salvagno G, Canè S, Fava C, Mazzaferri F, Carrara E, Petrova V, Barouni RM, Dima F, Dalbeni A, Romano S, Poli G, Benati M, De Nitto S, Mansueto G, Iezzi M, Tacconelli E, Lippi G, Bronte V, Minuz P. Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia. Arterioscler Thromb Vasc Biol 2020;40:2975-89. [PMID: 33052054 DOI: 10.1161/ATVBAHA.120.315175] [Cited by in Crossref: 33] [Cited by in F6Publishing: 77] [Article Influence: 16.5] [Reference Citation Analysis]
119 Jensen MP, George M, Gilroy D, Sofat R. Beyond dexamethasone, emerging immuno-thrombotic therapies for COVID-19. Br J Clin Pharmacol 2021;87:845-57. [PMID: 32881064 DOI: 10.1111/bcp.14540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
120 Hajra A, Mathai SV, Ball S, Bandyopadhyay D, Veyseh M, Chakraborty S, Lavie CJ, Aronow WS. Management of Thrombotic Complications in COVID-19: An Update. Drugs 2020;80:1553-62. [PMID: 32803670 DOI: 10.1007/s40265-020-01377-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
121 Ma A, Kase CS, Shoamanesh A, Abdalkader M, Pikula A, Sathya A, Catanese L, Ellis AT, Nguyen TN. Stroke and Thromboprophylaxis in the Era of COVID-19. Journal of Stroke and Cerebrovascular Diseases 2021;30:105392. [DOI: 10.1016/j.jstrokecerebrovasdis.2020.105392] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
122 Overmyer KA, Shishkova E, Miller IJ, Balnis J, Bernstein MN, Peters-Clarke TM, Meyer JG, Quan Q, Muehlbauer LK, Trujillo EA, He Y, Chopra A, Chieng HC, Tiwari A, Judson MA, Paulson B, Brademan DR, Zhu Y, Serrano LR, Linke V, Drake LA, Adam AP, Schwartz BS, Singer HA, Swanson S, Mosher DF, Stewart R, Coon JJ, Jaitovich A. Large-Scale Multi-omic Analysis of COVID-19 Severity. Cell Syst 2021;12:23-40.e7. [PMID: 33096026 DOI: 10.1016/j.cels.2020.10.003] [Cited by in Crossref: 90] [Cited by in F6Publishing: 169] [Article Influence: 45.0] [Reference Citation Analysis]
123 Frydman GH, Streiff MB, Connors JM, Piazza G. The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents. TH Open 2020;4:e288-99. [PMID: 33043235 DOI: 10.1055/s-0040-1718415] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
124 Ooi MWX, Rajai A, Patel R, Gerova N, Godhamgaonkar V, Liong SY. Pulmonary thromboembolic disease in COVID-19 patients on CT pulmonary angiography - Prevalence, pattern of disease and relationship to D-dimer. Eur J Radiol 2020;132:109336. [PMID: 33069986 DOI: 10.1016/j.ejrad.2020.109336] [Cited by in Crossref: 18] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
125 Franco-Moreno A, Herrera-Morueco M, Mestre-Gómez B, Muñoz-Rivas N, Abad-Motos A, Salazar-Chiriboga D, Duffort-Falcó M, Medrano-Izquierdo P, Bustamante-Fermosel A, Pardo-Guimera V, Ulla-Anés M, Torres-Macho J; Infanta Leonor Thrombosis Research Group. Incidence of Deep Venous Thrombosis in Patients With COVID-19 and Pulmonary Embolism: Compression Ultrasound COVID Study. J Ultrasound Med 2021;40:1411-6. [PMID: 33017480 DOI: 10.1002/jum.15524] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
126 Nopp S, Moik F, Jilma B, Pabinger I, Ay C. Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis. Res Pract Thromb Haemost 2020. [PMID: 33043231 DOI: 10.1002/rth2.12439] [Cited by in Crossref: 83] [Cited by in F6Publishing: 165] [Article Influence: 41.5] [Reference Citation Analysis]
127 Bikdeli B, Talasaz AH, Rashidi F, Sharif-Kashani B, Farrokhpour M, Bakhshandeh H, Sezavar H, Dabbagh A, Beigmohammadi MT, Payandemehr P, Yadollahzadeh M, Riahi T, Khalili H, Jamalkhani S, Rezaeifar P, Abedini A, Lookzadeh S, Shahmirzaei S, Tahamtan O, Matin S, Amin A, Parhizgar SE, Jimenez D, Gupta A, Madhavan MV, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Maleki M, Sadeghian S, Mohebbi B, Piazza G, Kirtane AJ, Lip GYH, Krumholz HM, Goldhaber SZ, Sadeghipour P. Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies. Thromb Res 2020;196:382-94. [PMID: 32992075 DOI: 10.1016/j.thromres.2020.09.027] [Cited by in Crossref: 25] [Cited by in F6Publishing: 37] [Article Influence: 12.5] [Reference Citation Analysis]
128 Birk R, Shaw D, Kennedy C, Higashi Y, Patel R, Gupta A, Au-Yong I. Low Detection Rate of Pulmonary Embolism in Patients Presenting to the Emergency Department With Suspected Coronavirus Disease 2019 (COVID-19): A Single-Centre UK Study. Curr Probl Diagn Radiol 2021;50:656-61. [PMID: 33036814 DOI: 10.1067/j.cpradiol.2020.09.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
129 Gerotziafas GT, Sergentanis TN, Voiriot G, Lassel L, Papageorgiou C, Elabbadi A, Turpin M, Vandreden P, Papageorgiou L, Psaltopoulou T, Terpos E, Dimopoulos MA, Parrot A, Cadranel J, Pialoux G, Fartoukh M, Elalamy I. Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19. Thromb Haemost 2020;120:1680-90. [PMID: 32961572 DOI: 10.1055/s-0040-1716544] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
130 Iturbe-Hernandez T, García de Guadiana Romualdo L, Gil Ortega I, Martínez Francés A, Meca Birlanga O, Cerezo-Manchado JJ. Dabigatran, the oral anticoagulant of choice at discharge in patients with non-valvular atrial fibrillation and COVID-19 infection: the ANIBAL protocol. Drugs Context 2020;9:2020-8-3. [PMID: 33014097 DOI: 10.7573/dic.2020-8-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
131 Fedele D, De Francesco A, Riso S, Collo A. Obesity, malnutrition, and trace element deficiency in the coronavirus disease (COVID-19) pandemic: An overview.Nutrition. 2021;81:111016. [PMID: 33059127 DOI: 10.1016/j.nut.2020.111016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
132 White D, MacDonald S, Edwards T, Bridgeman C, Hayman M, Sharp M, Cox-Morton S, Duff E, Mahajan S, Moore C, Kirk M, Williams R, Besser M, Thomas W. Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays. Int J Lab Hematol 2021;43:123-30. [PMID: 32892505 DOI: 10.1111/ijlh.13329] [Cited by in Crossref: 14] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
133 Eriksson O, Hultström M, Persson B, Lipcsey M, Ekdahl KN, Nilsson B, Frithiof R. Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients. Thromb Haemost 2020;120:1720-4. [PMID: 32871607 DOI: 10.1055/s-0040-1715835] [Cited by in Crossref: 22] [Cited by in F6Publishing: 38] [Article Influence: 11.0] [Reference Citation Analysis]
134 Zerwes S, Steinbauer M, Gosslau Y, Warm T, Hyhlik-Dürr A. [COVID-19 infection-Risk of thromboembolic complications]. Gefasschirurgie 2020;:1-6. [PMID: 32905019 DOI: 10.1007/s00772-020-00687-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
135 Mancuso P, Gidaro A, Gregato G, Raveane A, Cremonesi P, Quarna J, Caccia S, Gusso L, Rusconi S, Giacomelli A, Cogliati C, Bertolini F. Circulating endothelial progenitors are increased in COVID-19 patients and correlate with SARS-CoV-2 RNA in severe cases. J Thromb Haemost 2020;18:2744-50. [PMID: 32762140 DOI: 10.1111/jth.15044] [Cited by in Crossref: 13] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
136 Kermani-Alghoraishi M, Ghahramani R. A Review of Venous Thromboembolism Phenomena in COVID-19 Patients. Curr Probl Cardiol 2021;46:100692. [PMID: 32994052 DOI: 10.1016/j.cpcardiol.2020.100692] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
137 Lax SF, Skok K, Trauner M; all coauthors. Pulmonary arterial thrombosis as an important complication of COVID-19 pulmonary disease: letter to the editor. Virchows Arch 2020;477:467-8. [PMID: 32772159 DOI: 10.1007/s00428-020-02896-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
138 Mezalek ZT, Khibri H, Ammouri W, Bouaouad M, Haidour S, Harmouche H, Maamar M, Adnaoui M. COVID-19 Associated Coagulopathy and Thrombotic Complications. Clin Appl Thromb Hemost. 2020;26:1076029620948137. [PMID: 32795186 DOI: 10.1177/1076029620948137] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
139 Haimei MA. Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications. Clin Appl Thromb Hemost 2020;26:1076029620944497. [PMID: 32722927 DOI: 10.1177/1076029620944497] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
140 Godoy LC, Goligher EC, Lawler PR, Slutsky AS, Zarychanski R. Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19. CMAJ 2020;192:E1156-61. [PMID: 32816822 DOI: 10.1503/cmaj.201240] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
141 Moazzam M, Sajid MI, Shahid H, Butt J, Bashir I, Jamshaid M, Shirazi AN, Tiwari RK. Understanding COVID-19: From Origin to Potential Therapeutics. Int J Environ Res Public Health 2020;17:E5904. [PMID: 32823901 DOI: 10.3390/ijerph17165904] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
142 Porfidia A, Valeriani E, Pola R, Porreca E, Rutjes AWS, Di Nisio M. Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis. Thromb Res 2020;196:67-74. [PMID: 32853978 DOI: 10.1016/j.thromres.2020.08.020] [Cited by in Crossref: 57] [Cited by in F6Publishing: 99] [Article Influence: 28.5] [Reference Citation Analysis]
143 Pendower L, Benedetti G, Breen K, Karunanithy N. Catheter-directed thrombolysis to treat acute pulmonary thrombosis in a patient with COVID-19 pneumonia. BMJ Case Rep 2020;13:e237046. [PMID: 32784245 DOI: 10.1136/bcr-2020-237046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
144 Callender LA, Curran M, Bates SM, Mairesse M, Weigandt J, Betts CJ. The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19. Front Immunol 2020;11:1991. [PMID: 32903476 DOI: 10.3389/fimmu.2020.01991] [Cited by in Crossref: 23] [Cited by in F6Publishing: 52] [Article Influence: 11.5] [Reference Citation Analysis]
145 Siegal DM, Gross PL. Narrowing in on the True Rate of Venous Thromboembolism in Hospitalized Patients With COVID-19 Disease. Arterioscler Thromb Vasc Biol 2020;40:1958-60. [PMID: 32762455 DOI: 10.1161/ATVBAHA.120.314977] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
146 Pizzolo F, Rigoni AM, De Marchi S, Friso S, Tinazzi E, Sartori G, Stefanoni F, Nalin F, Montagnana M, Pilotto S, Milella M, Azzini AM, Tacconelli E, Marchi G, Girelli D, Olivieri O, Martinelli N. Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg. Thromb Res. 2020;194:216-219. [PMID: 33074107 DOI: 10.1016/j.thromres.2020.08.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
147 Lakshmanan HHS, Pore AA, Kohs TCL, Yazar F, Thompson RM, Jurney PL, Maddala J, Olson SR, Shatzel JJ, Vanapalli SA, McCarty OJT. Design of a Microfluidic Bleeding Chip to Evaluate Antithrombotic Agents for Use in COVID-19 Patients. Cell Mol Bioeng 2020;:1-9. [PMID: 32837586 DOI: 10.1007/s12195-020-00644-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
148 D'Souza R, Malhamé I, Teshler L, Acharya G, Hunt BJ, McLintock C. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19. Acta Obstet Gynecol Scand 2020;99:1110-20. [PMID: 32678949 DOI: 10.1111/aogs.13962] [Cited by in Crossref: 21] [Cited by in F6Publishing: 31] [Article Influence: 10.5] [Reference Citation Analysis]
149 Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, Goodarzi K, Bendapudi PK, Bornikova L, Gupta S, Leaf DE, Kuter DJ, Rosovsky RP. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136:489-500. [PMID: 32492712 DOI: 10.1182/blood.2020006520] [Cited by in Crossref: 383] [Cited by in F6Publishing: 588] [Article Influence: 191.5] [Reference Citation Analysis]
150 Chi G, Lee JJ, Jamil A, Gunnam V, Najafi H, Memar Montazerin S, Shojaei F, Marszalek J. Venous Thromboembolism among Hospitalized Patients with COVID-19 Undergoing Thromboprophylaxis: A Systematic Review and Meta-Analysis. J Clin Med 2020;9:E2489. [PMID: 32756383 DOI: 10.3390/jcm9082489] [Cited by in Crossref: 37] [Cited by in F6Publishing: 54] [Article Influence: 18.5] [Reference Citation Analysis]
151 Lopachev AV, Kazanskaya RB, Khutorova AV, Fedorova TN. An overview of the pathogenic mechanisms involved in severe cases of COVID-19 infection, and the proposal of salicyl-carnosine as a potential drug for its treatment. Eur J Pharmacol 2020;886:173457. [PMID: 32750366 DOI: 10.1016/j.ejphar.2020.173457] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
152 Ramacciotti E, Macedo AS, Biagioni RB, Caffaro RA, Lopes RD, Guerra JC, Orsi FA, Marques MA, Tafur AJ, Caprini JA, Nicolaides A, Carter CA, Filho CC, Fareed J. Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020. Clin Appl Thromb Hemost 2020;26:1076029620936350. [PMID: 32649232 DOI: 10.1177/1076029620936350] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
153 Dragonetti D, Guarini G, Pizzuti M. Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy. Blood Transfus 2020;18:328. [PMID: 32697931 DOI: 10.2450/2020.0164-20] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
154 Turi S, Nardelli P, Landoni G. Anticoagulants and immunosuppressants in COVID-19: Bullets to Defeat MicroCLOTS. Ann Card Anaesth 2020;23:258-9. [PMID: 32687078 DOI: 10.4103/aca.ACA_126_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
155 Turshudzhyan A. SARS-CoV2 induced pulmonary embolism and complications from anticoagulation. Respir Med Case Rep 2020;31:101176. [PMID: 32834986 DOI: 10.1016/j.rmcr.2020.101176] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
156 Lisi L, Lacal PM, Barbaccia ML, Graziani G. Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2. Biochem Pharmacol 2020;180:114169. [PMID: 32710969 DOI: 10.1016/j.bcp.2020.114169] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
157 Ayerbe L, Risco C, Ayis S. The association between treatment with heparin and survival in patients with Covid-19. J Thromb Thrombolysis. 2020;50:298-301. [PMID: 32476080 DOI: 10.1007/s11239-020-02162-z] [Cited by in Crossref: 69] [Cited by in F6Publishing: 96] [Article Influence: 34.5] [Reference Citation Analysis]
158 Overmyer KA, Shishkova E, Miller IJ, Balnis J, Bernstein MN, Peters-Clarke TM, Meyer JG, Quan Q, Muehlbauer LK, Trujillo EA, He Y, Chopra A, Chieng HC, Tiwari A, Judson MA, Paulson B, Brademan DR, Zhu Y, Serrano LR, Linke V, Drake LA, Adam AP, Schwartz BS, Singer HA, Swanson S, Mosher DF, Stewart R, Coon JJ, Jaitovich A. Large-scale Multi-omic Analysis of COVID-19 Severity. medRxiv 2020:2020. [PMID: 32743614 DOI: 10.1101/2020.07.17.20156513] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
159 Mackman N, Antoniak S, Wolberg AS, Kasthuri R, Key NS. Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses. Arterioscler Thromb Vasc Biol 2020;40:2033-44. [PMID: 32657623 DOI: 10.1161/ATVBAHA.120.314514] [Cited by in Crossref: 47] [Cited by in F6Publishing: 83] [Article Influence: 23.5] [Reference Citation Analysis]
160 Marietta M, Coluccio V, Luppi M. COVID-19, coagulopathy and venous thromboembolism: more questions than answers. Intern Emerg Med 2020;15:1375-87. [PMID: 32653981 DOI: 10.1007/s11739-020-02432-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 45] [Article Influence: 16.5] [Reference Citation Analysis]
161 Weiss E, Roux O, Moyer JD, Paugam-Burtz C, Boudaoud L, Ajzenberg N, Faille D, de Raucourt E. Fibrinolysis Resistance: A Potential Mechanism Underlying COVID-19 Coagulopathy. Thromb Haemost 2020;120:1343-5. [PMID: 32645725 DOI: 10.1055/s-0040-1713637] [Cited by in Crossref: 13] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
162 Zerwes S, Hernandez Cancino F, Liebetrau D, Gosslau Y, Warm T, Märkl B, Hyhlik-Dürr A. [Increased risk of deep vein thrombosis in intensive care unit patients with CoViD-19 infections?-Preliminary data]. Chirurg 2020;91:588-94. [PMID: 32504106 DOI: 10.1007/s00104-020-01222-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
163 Lobastov KV, Schastlivtsev IV, Porembskaya OY, Dzenina OV, Bargandzhiya AB, Tsaplin SN. COVID-19-associated coagulopathy: review of current recommendations for diagnosis, treatment and prevention. Ambulatornaya khirurgiya 2020. [DOI: 10.21518/1995-1477-2020-3-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
164 Harenberg J, Favaloro E. COVID-19: progression of disease and intravascular coagulation - present status and future perspectives. Clin Chem Lab Med 2020;58:1029-36. [PMID: 32406381 DOI: 10.1515/cclm-2020-0502] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 20.0] [Reference Citation Analysis]
165 Patel I, Akoluk A, Douedi S, Upadhyaya V, Mazahir U, Costanzo E, Flynn D. Life-Threatening Psoas Hematoma due to Retroperitoneal Hemorrhage in a COVID-19 Patient on Enoxaparin Treated With Arterial Embolization: A Case Report. J Clin Med Res. 2020;12:458-461. [PMID: 32655742 DOI: 10.14740/jocmr4256] [Cited by in Crossref: 11] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
166 Morici N, Bottiroli M, Fumagalli R, Marini C, Cattaneo M. Role of von Willebrand Factor and ADAMTS-13 in the Pathogenesis of Thrombi in SARS-CoV-2 Infection: Time to Rethink. Thromb Haemost 2020;120:1339-42. [PMID: 32575136 DOI: 10.1055/s-0040-1713400] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 9.5] [Reference Citation Analysis]
167 Maley JH, Petri CR, Brenner LN, Chivukula RR, Calhoun TF, Vinarsky V, Hardin CC. Anticoagulation, immortality, and observations of COVID-19. Res Pract Thromb Haemost 2020;4:674-6. [PMID: 32685874 DOI: 10.1002/rth2.12398] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
168 Susen S, Tacquard CA, Godon A, Mansour A, Garrigue D, Nguyen P, Godier A, Testa S, Levy JH, Albaladejo P, Gruel Y; GIHP and GFHT. Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring. Crit Care 2020;24:364. [PMID: 32560658 DOI: 10.1186/s13054-020-03000-7] [Cited by in Crossref: 61] [Cited by in F6Publishing: 76] [Article Influence: 30.5] [Reference Citation Analysis]
169 Cagnacci A, Bonaccorsi G, Gambacciani M; board of the Italian Menopause Society. Reflections and recommendations on the COVID-19 pandemic: Should hormone therapy be discontinued? Maturitas 2020;138:76-7. [PMID: 32565009 DOI: 10.1016/j.maturitas.2020.05.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
170 Romagnoli S, Peris A, De Gaudio AR, Geppetti P. SARS-CoV-2 and COVID-19: From the Bench to the Bedside.Physiol Rev. 2020;100:1455-1466. [PMID: 32496872 DOI: 10.1152/physrev.00020.2020] [Cited by in Crossref: 56] [Cited by in F6Publishing: 69] [Article Influence: 28.0] [Reference Citation Analysis]
171 Desborough MJR, Doyle AJ, Griffiths A, Retter A, Breen KA, Hunt BJ. Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom. Thromb Res 2020;193:1-4. [PMID: 32485437 DOI: 10.1016/j.thromres.2020.05.049] [Cited by in Crossref: 65] [Cited by in F6Publishing: 75] [Article Influence: 32.5] [Reference Citation Analysis]
172 Cattaneo M, Morici N. Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial. Blood Transfus 2020;18:237-8. [PMID: 32453692 DOI: 10.2450/2020.0109-20] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
173 Mutti L, Pentimalli F, Baglio G, Maiorano P, Saladino RE, Correale P, Giordano A. Coronavirus Disease (Covid-19): What Are We Learning in a Country With High Mortality Rate? Front Immunol 2020;11:1208. [PMID: 32574270 DOI: 10.3389/fimmu.2020.01208] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
174 Al-Ani F, Chehade S, Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res 2020;192:152-60. [PMID: 32485418 DOI: 10.1016/j.thromres.2020.05.039] [Cited by in Crossref: 139] [Cited by in F6Publishing: 172] [Article Influence: 69.5] [Reference Citation Analysis]
175 Mahan K, Kabrhel C, Goldsmith AJ. Abdominal pain in a patient with COVID-19 infection: A case of multiple thromboemboli. Am J Emerg Med 2020;38:2245.e3-5. [PMID: 32513452 DOI: 10.1016/j.ajem.2020.05.054] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
176 Dalager-Pedersen M, Bodilsen J. Thromboprophylaxis for medical inpatients with coronavirus disease 2019. Clin Microbiol Infect 2020;26:1125-6. [PMID: 32454190 DOI: 10.1016/j.cmi.2020.05.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
177 [DOI: 10.1101/2020.05.11.088500] [Cited by in Crossref: 35] [Cited by in F6Publishing: 12] [Reference Citation Analysis]